Evidence map›Paper›PMID 31170059›Full record

ArticleCirculation research2019

Complement Membrane Attack Complexes Assemble NLRP3 Inflammasomes Triggering IL-1 Activation of IFN-γ-Primed Human Endothelium.

Catherine B Xie, Lingfeng Qin, Guangxin Li, Caodi Fang, Nancy C Kirkiles-Smith, George Tellides, Jordan S Pober, Dan Jane-Wit

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Circulation research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Vascular Aging.Circulation · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Roles of endothelial cells during infection.Current opinion in immunology · 2025
    Review
  12. Emerging roles for complement in lung transplantation.The Journal of clinical investigation · 2025
    Review
  13. Article
  14. Review
  15. Disseminated intravascular coagulation.Journal of intensive care · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Catherine B XieFrom the Department of Immunobiology (C.B.X., N.C.K.-S., J.S.P.), Yale University School of Medicine, New Haven, CT.
Lingfeng QinDepartment of Surgery (L.Q., G.L., G.T.), Yale University School of Medicine, New Haven, CT.
Guangxin LiDepartment of Surgery (L.Q., G.L., G.T.), Yale University School of Medicine, New Haven, CT.
Caodi FangDivision of Cardiovascular Medicine (C.F., D.J.-w), Yale University School of Medicine, New Haven, CT.
Nancy C Kirkiles-SmithFrom the Department of Immunobiology (C.B.X., N.C.K.-S., J.S.P.), Yale University School of Medicine, New Haven, CT.
George TellidesDepartment of Surgery (L.Q., G.L., G.T.), Yale University School of Medicine, New Haven, CT.
Jordan S PoberFrom the Department of Immunobiology (C.B.X., N.C.K.-S., J.S.P.), Yale University School of Medicine, New Haven, CT.
Dan Jane-WitDivision of Cardiovascular Medicine (C.F., D.J.-w), Yale University School of Medicine, New Haven, CT.
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Presentation of Alloantigen by Human Vascular CellsR01HL051014 · NHLBI · YALE UNIVERSITY · PI MANES, THOMAS DAVID, POBER, JORDAN S · 1994 to 2019
$10.4M
Yale Rheumatic Diseases Research Core CenterP30AR053495 · NIAMS · YALE UNIVERSITY · PI SHLOMCHIK, MARK J · 2007 to 2017
$7.0M
THE ROLE OF ZFYVE21 IN CEREBRAL AMYLOID ANGIOPATHY IN ALZHEIMER'S DISEASER01HL141137 · NHLBI · YALE UNIVERSITY · PI JANE-WIT, DANIEL · 2018 to 2022
$2.6M
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft EndotheliumU01AI132895 · NIAID · YALE UNIVERSITY · PI POBER, JORDAN S, SALTZMAN, W. MARK · 2017 to 2021
$2.2M
Mechanisms of Non-Canonical NF-kB Activation in Transplant ArteriosclerosisR00HL125895 · NHLBI · YALE UNIVERSITY · PI JANE-WIT, DANIEL · 2017 to 2019
$732k
Complement Induces Inflammasome Assembly in Human Endothelium: Mechanisms and Consequences for Graft RejectionF30AI138473 · NIAID · YALE UNIVERSITY · PI XIE, CATHERINE BINGCHAN · 2018 to 2021
$140k
Department of HealthNCATS NIH HHS UL1 TR001863NHLBI NIH HHS R00 HL125895NHLBI NIH HHS R01 HL051014NHLBI NIH HHS R01 HL141137NIAID NIH HHS F30 AI138473NIAID NIH HHS U01 AI132895NIAMS NIH HHS P30 AR053495NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

rationaleComplement activation contributes to multiple immune-mediated pathologies. In late allograft failure, donor-specific antibody deposits complement membrane attack complexes (MAC) on graft endothelial cells (ECs), substantially increasing their immunogenicity without causing lysis. Internalized MAC stabilize NIK (NF-κB [nuclear factor kappa-light-chain-enhancer of activated B cells]-inducing kinase) protein on Rab5+MAC+ endosomes, activating noncanonical NF-κB signaling. However, the link to increased immunogenicity is unclear.

objectiveTo identify mechanisms by which alloantibody and internalized MAC activate ECs to enhance their ability to increase T-cell responses. METHODS AND

resultsIn human EC cultures, internalized MAC also causes NLRP3 (NOD-like receptor family pyrin domain containing 3) translocation from endoplasmic reticulum to Rab5+MAC+NIK+ endosomes followed by endosomal NIK-dependent inflammasome assembly. Cytosolic NIK, stabilized by LIGHT (lymphotoxin-like inducible protein that competes with glycoprotein D for herpesvirus entry on T cells), does not trigger inflammasome assembly, and ATP-triggered inflammasome assembly does not require NIK. IFN-γ (interferon-γ) primes EC responsiveness to MAC by increasing NLRP3, pro-caspase 1, and gasdermin D expression. NIK-activated noncanonical NF-κB signaling induces pro-IL (interleukin)-1β expression. Inflammasome processed pro-IL-1β, and gasdermin D results in IL-1β secretion that increases EC immunogenicity through IL-1 receptor signaling. Activation of human ECs lining human coronary artery grafts in immunodeficient mouse hosts by alloantibody and complement similarly depends on assembly of an NLRP3 inflammasome. Finally, in renal allograft biopsies showing chronic rejection, caspase-1 is activated in C4d

conclusionsIn response to antibody-mediated complement activation, IFN-γ-primed human ECs internalize MAC, triggering both endosomal-associated NIK-dependent NLRP3 inflammasome assembly and IL-1 synthesis, resulting in autocrine/paracrine IL-1β-mediated increases in EC immunogenicity. Similar responses may underlie other complement-mediated pathologies.

Indexed as

AdultCells, CulturedComplement Membrane Attack ComplexEndothelium, VascularFemaleHEK293 CellsHumansHuman Umbilical Vein Endothelial CellsInflammasomesInterferon-gammaInterleukin-1MaleNLR Family, Pyrin Domain-Containing 3 ProteinComplement Membrane Attack ComplexInflammasomesInterferon-gammaInterleukin-1NLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanendosomesendotheliumimmune systeminflammasomestransplantation

Identifiers

PMID31170059
PMCPMC6557295
OpenAlexW2940337896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.